MS. ANITA SHALLAL M.D.
Prescription History 1134570823
Internal Medicine - Infectious Disease in Detroit, MI
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MS. ANITA SHALLAL M.D., an active Infectious Disease specialist practicing in Detroit, MI. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 63 documented patient claims. Among these therapy options, the most frequently utilized medication is Ethambutol Hcl, which accounts for 17 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MI PrescribersVs. MI Avg |
|---|---|---|---|
| Ethambutol Hcl | 17 | $41.30▼ below MI avg | ≈ Typical |
About Ethambutol Hcl: Ethambutol is used with other medications to treat tuberculosis (TB). Show more ▾ Ethambutol is an antibiotic and works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) In 2024, this provider wrote 17 Medicare prescriptions for Ethambutol Hcl, about the same volume as the typical Michigan prescriber of this medication (17.5). Medicare paid an average of $41.30 per fill, versus $56.96 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 26.8 30-Day Fills standardized to 30-day supplies 796 Days of Medication total across all patients in 2024 | |||
| Rifampin | 17 | $110.88 | ≈ Typical |
About Rifampin: This medication is used to prevent and treat tuberculosis and other bacterial infections. Show more ▾ Rifampin belongs to a class of drugs known as rifamycin antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) In 2024, this provider wrote 17 Medicare prescriptions for Rifampin, about the same volume as the typical Michigan prescriber of this medication (18.1). Medicare paid an average of $110.88 per fill, versus $70.09 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 836 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 16 | $21.62 | ▼ Less than typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 16 Medicare prescriptions for Azithromycin, about half the volume of the typical Michigan prescriber of this medication (34.6). Medicare paid an average of $21.62 per fill, versus $5.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.8 30-Day Fills standardized to 30-day supplies 823 Days of Medication total across all patients in 2024 | |||
| DovatoDolutegravir Sodium/Lamivudine | 13 | $2,785.99▼ below MI avg | ▼ Less than typical |
About Dovato: This product contains 2 drugs: dolutegravir and lamivudine. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Lamivudine belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Dolutegravir belongs to a class of drugs known as integrase inhibitors. This medication is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 13 Medicare prescriptions for Dovato, about half the volume of the typical Michigan prescriber of this medication (29). Medicare paid an average of $2,785.99 per fill, versus $3,008.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MS. ANITA SHALLAL M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Infectious Disease prescribing approach at this Detroit, MI practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MI prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
